Hydroxychloroquine in Outpatient Adults With COVID-19
NCT04333654
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
8
Enrollment
INDUSTRY
Sponsor class
Stopped
Rate of enrollment too slow to allow completion in a reasonable timeframe
Conditions
Coronavirus Infection
Interventions
DRUG:
Hydroxychloroquine SAR321068
DRUG:
Placebo
Sponsor
Sanofi